Cargando…

Novel insights into the mechanism of action of lenalidomide

Detalles Bibliográficos
Autores principales:	Semeraro, Michaela, Galluzzi, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203586/ https://www.ncbi.nlm.nih.gov/pubmed/25340011 http://dx.doi.org/10.4161/onci.28386

Ejemplares similares

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Mechanism of action of lenalidomide in hematological malignancies
por: Kotla, Venumadhav, et al.
Publicado: (2009)

Lenalidomide in the Treatment of Lymphoproliferative Disorders and Multiple Myeloma
por: Liberati, Anna Marina, et al.
Publicado: (2013)

Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
por: McDaniel, Jessica M., et al.
Publicado: (2012)

Prognostic impact of Ikaros expression in lenalidomide-treated multiple myeloma
por: Krönke, Jan, et al.
Publicado: (2017)

New immunotherapeutic paradigms for castration-resistant prostate cancer
por: Galluzzi, Lorenzo
Publicado: (2013)

Heterogeneous cellular effects of α-ketoglutarate esters
por: Galluzzi, Lorenzo
Publicado: (2019)

New Insights into Antibacterial Compounds: From Synthesis and Discovery to Molecular Mechanisms of Action
por: Leitão, Jorge H.
Publicado: (2020)

Novel Insights into Molecular Mechanisms of Chronic Pain
por: Niederberger, Ellen
Publicado: (2020)

Novel Insights into Molecular Mechanisms of Endometrial Diseases
por: Golia D’Augè, Tullio, et al.
Publicado: (2023)

Novel Insights into the Mechanisms of Microbial Transcription and Translation
por: Sarin, L. Peter
Publicado: (2023)

Molecular and Cellular Oncology: A new journal for a changing field
por: Galluzzi, Lorenzo, et al.
Publicado: (2014)

Amino acid deprivation promotes intestinal homeostasis through autophagy
por: Galluzzi, Lorenzo, et al.
Publicado: (2016)

Mitochondrial control of innate immune signaling by irradiated cancer cells
por: Yamazaki, Takahiro, et al.
Publicado: (2020)

Impact of treatment schedule on the efficacy of cytostatic and immunostimulatory agents
por: Petroni, Giulia, et al.
Publicado: (2021)

Cell death and senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2023)

Novel Anti-Cancer Agents and Cellular Targets and Their Mechanism(s) of Action
por: Allison, Simon J.
Publicado: (2022)

Immunology of Cell Death in Cancer Immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2021)

A novel nano‐immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single‐cell RNA‐sequencing
por: Liu, Yang, et al.
Publicado: (2022)

Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma
por: Krejcik, Jakub, et al.
Publicado: (2018)

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma
por: Lund, Johan, et al.
Publicado: (2018)

Novel Molecular Mechanism of Lenalidomide in Myeloid Malignancies Independent of Deletion of Chromosome 5q
por: Park, Isaac, et al.
Publicado: (2021)

Combination of lenalidomide and vitamin D enhances MOR202-mediated cytotoxicity of macrophages: It takes three to tango
por: Flamann, Cindy, et al.
Publicado: (2019)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Immunological effects of chemotherapy in spontaneous breast cancers
por: Kroemer, Guido, et al.
Publicado: (2013)

Victories and deceptions in tumor immunology: Stimuvax(®)
por: Kroemer, Guido, et al.
Publicado: (2013)

Mechanisms of Adiponectin Action
por: Fiaschi, Tania
Publicado: (2019)

Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins
por: Panova, Natalya, et al.
Publicado: (2015)

Lenalidomide-Associated ITP
por: Herold, Christina I., et al.
Publicado: (2011)

Bioactive Molecules and Their Mechanisms of Action
por: Wang, Dongdong, et al.
Publicado: (2019)

Mechanisms of Plant Antioxidants Action
por: Barreca, Davide
Publicado: (2020)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes
por: Giagounidis, Aristoteles, et al.
Publicado: (2013)

Ganoderma lucidum: Novel Insight into Hepatoprotective Potential with Mechanisms of Action
por: Ahmad, Md Faruque, et al.
Publicado: (2023)

Mechanisms of metformin action: In and out of the gut
por: Minamii, Takahiro, et al.
Publicado: (2018)

Molecular Mechanism of Action of Neonicotinoid Insecticides
por: Thany, Steeve H.
Publicado: (2023)

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment
por: Dimopoulos, M A, et al.
Publicado: (2017)

Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal
por: Geyer, Mark B., et al.
Publicado: (2023)

Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma
por: Chiu, Hsiling, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_40t3jpn85ldn0dd9dgic0esrer